Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
216 articles
21 of 22
Building digital therapeutics studies for the FDA vs. payers
10.04.19
15
min. Read
Senate bill mentions DTx. Pear lobbying. FDA vs payers.
10.04.19
6
min. Read
Trouble in Pear-adise? More details on ESI’s digital formulary.
9.27.19
8
min. Read
Excerpts from the Pear Therapeutics Report.
9.13.19
2
min. Read
Novartis predicts Amazon DTx delivery. VR pain relief.
8.22.19
5
min. Read
Samsung’s quiet CardioBand FDA clearance. HealthXL’s evidence report.
8.08.19
4
min. Read
CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.
8.01.19
5
min. Read
The case against Proteus-Otsuka’s digital med. AliveCor’s 6th CEO
7.25.19
4
min. Read
FDA Pre-Cert tested with Pear insomnia DTx.
7.18.19
7
min. Read
Germany passes DTx formulary, payment law. Outcomes over Exits?
7.11.19
6
min. Read
1 of 22